Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Apr;29(4):795-796.
doi: 10.1038/s41591-023-02231-9.

Clinicogenomic landscape of morphological evolution in lung adenocarcinoma

No authors listed
Comment

Clinicogenomic landscape of morphological evolution in lung adenocarcinoma

No authors listed. Nat Med. 2023 Apr.
No abstract available

PubMed Disclaimer

Comment on

  • Evolutionary characterization of lung adenocarcinoma morphology in TRACERx.
    Karasaki T, Moore DA, Veeriah S, Naceur-Lombardelli C, Toncheva A, Magno N, Ward S, Bakir MA, Watkins TBK, Grigoriadis K, Huebner A, Hill MS, Frankell AM, Abbosh C, Puttick C, Zhai H, Gimeno-Valiente F, Saghafinia S, Kanu N, Dietzen M, Pich O, Lim EL, Martínez-Ruiz C, Black JRM, Biswas D, Campbell BB, Lee C, Colliver E, Enfield KSS, Hessey S, Hiley CT, Zaccaria S, Litchfield K, Birkbak NJ, Cadieux EL, Demeulemeester J, Van Loo P, Adusumilli PS, Tan KS, Cheema W, Sanchez-Vega F, Jones DR, Rekhtman N, Travis WD, Hackshaw A, Marafioti T, Salgado R, Le Quesne J, Nicholson AG; TRACERx Consortium; McGranahan N, Swanton C, Jamal-Hanjani M. Karasaki T, et al. Nat Med. 2023 Apr;29(4):833-845. doi: 10.1038/s41591-023-02230-w. Epub 2023 Apr 12. Nat Med. 2023. PMID: 37045996 Free PMC article.

References

    1. Nicholson, A. G. et al. The 2021 WHO Classification of Lung Tumors: Impact of Advances Since 2015. J. Thorac. Oncol. 17, 362–387 (2022). This review highlights the most recent changes to the international classification of lung tumors, including the relevance of LUAD growth pattern fractions and STAS. - DOI - PubMed
    1. Frankell, A. M. et al. The evolution of lung cancer and impact of subclonal selection in TRACERx. Nature (in the press, 2023). This TRACERx paper describes determinants of smoking mutagenesis, subclonal selection during tumor development and the relevance of primary tumor genomic heterogeneity to future patterns of disease relapse.
    1. Al Bakir, M. et al. The evolution of non-small lung cancer metastases in TRACERx 421. Nature (in the press, 2023). This TRACERx paper characterizes metastatic subclones, describes the timing and patterns of metastatic dissemination and explores the role of selection in metastases.
    1. Martinez-Ruiz, C. et al. Genomic-transcriptomic evolution in lung cancer and metastasis. Nature (in the press, 2023). This TRACERx paper describes the interplay between genomic features and transcriptional processes affecting tumor evolution and the metastatic transition.
    1. Abbosh, C. et al. Phylogenetic ctDNA profiling of metastatic dissemination in lung cancer. Nature (in the press, 2023). This TRACERx paper addresses prognostic implications of pre- and post-operative ctDNA detection and non-invasive profiling of metastatic dissemination class.

MeSH terms

LinkOut - more resources